Medical Director Kidney and Pancreas Transplant Program Texas Transplant Institute Vice Chief of Staff Methodist Specialty and Transplant Hospital

Nephrology

Dr. Matthias H. Kapturczak, MD


Dr. Matthias H. Kapturczak practices Nephrology. He received awards:"Top Doctors:SE Texas" and "Meaningful Use Stage 1 Certification". Matthias H. Kapturczak, MD has written publications. He has 14 publications published with PubMed. The lastest paper is: 'Diffusion of nitric oxide in the aorta wall monitored in situ by porphyrinic microsensors.' He accepts Medicare payments and is listed with Medicare.gov.



Publications


Schools


Procedures Preformed


Conditions Treated


Doctors Specialties


Accepted Insurances


Awards


Education


Drug Facts


NPI NUMBER   1861429755
NPPES Provider LastName   KAPTURCZAK
NPPES Provider FirstName   MATTHIAS
NPPES Provider ZIPCode   782293818
NPPES Provider State   TX
Specialty Description   Nephrology
Total Claim Count   1308.0
Distinct Opioid Count   1.0
Opioid Claim Count   25.0
Percent Opioid Claims   1.91

Helpful Reviews


Give Anonymous Review


Medicare Facts


National Provider Identifier [NPI] 1861429755
Last Name Of The Provider KAPTURCZAK
First Name Of The Provider MATTHIAS
View All

Similar Doctors


Dr. Terrance A. Fried, MD
This Doctor is OpenDoctor Recommended.
Dr. Jane M. Cannon, MD
This Doctor is OpenDoctor Recommended.
Dr. Stephen J. Park, MD
Dr. Patrick H. Peters Jr., MD
This Doctor is OpenDoctor Recommended.
Dr. Sayed K. Ali, MD
This Doctor is OpenDoctor Recommended.
Dr. Sohail Riaz, MD
This Doctor is OpenDoctor Recommended.
Dr. Michelle Conde, MD
This Doctor is OpenDoctor Recommended.
Dr. Zeba Gill, MD
This Doctor is OpenDoctor Recommended.
Dr. Carl J. Blond, MD
This Doctor is OpenDoctor Recommended.
Dr. David M. Player, MD
This Doctor is OpenDoctor Recommended.
Dr. Hana K. Kwan, MD
Dr. Pablo E. Pergola, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Meyer D. Lifschitz, MD
Dr. Rupal D. Patel, MD
Hitesh B. Singh


Doctor Directory | TOS | twitter | FB | Angel | blog